BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27032379)

  • 1. Expression of MMP and TIMP mRNA in peripheral blood leukocytes of patients with invasive ductal carcinoma of the breast.
    Wieczorek E; Galicki M; Tomasik B; Krol M; Jablonska E; Fendler W; Gromadzinska J; Morawiec Z; Wasowicz W; Reszka E
    Int J Biol Markers; 2016 Jul; 31(3):e309-16. PubMed ID: 27032379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
    Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
    Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.
    Gong YL; Xu GM; Huang WD; Chen LB
    J Surg Oncol; 2000 Feb; 73(2):95-9. PubMed ID: 10694645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.
    Kim HJ; Park CI; Park BW; Lee HD; Jung WH
    Yonsei Med J; 2006 Jun; 47(3):333-42. PubMed ID: 16807982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
    Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
    BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
    Decock J; Hendrickx W; Drijkoningen M; Wildiers H; Neven P; Smeets A; Paridaens R
    Dis Markers; 2007; 23(3):189-96. PubMed ID: 17473389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure.
    Barton PJ; Birks EJ; Felkin LE; Cullen ME; Koban MU; Yacoub MH
    J Heart Lung Transplant; 2003 Jul; 22(7):738-44. PubMed ID: 12873541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit.
    Feldman LJ; Mazighi M; Scheuble A; Deux JF; De Benedetti E; Badier-Commander C; Brambilla E; Henin D; Steg PG; Jacob MP
    Circulation; 2001 Jun; 103(25):3117-22. PubMed ID: 11425778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular aspects of collagenolysis associated with stress urinary incontinence in women with urethral hypermobility vs intrinsic sphincter deficiency.
    Candoso B; Meneses MJ; Alves MG; Sousa M; Oliveira PF
    Neurourol Urodyn; 2019 Aug; 38(6):1533-1539. PubMed ID: 31099099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma.
    Bramhall SR; Neoptolemos JP; Stamp GW; Lemoine NR
    J Pathol; 1997 Jul; 182(3):347-55. PubMed ID: 9349239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is determination of matrix metalloproteinases and their tissue inhibitors serum concentrations useful in patients with gastroenteropancreatic and bronchopulmonary neuroendocrine neoplasms?
    Blicharz-Dorniak J; Kos-Kudła B; Foltyn W; Kajdaniuk D; Marek B; Zemczak A; Strzelczyk J
    Endokrynol Pol; 2012; 63(6):470-6. PubMed ID: 23339005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.
    Piechota-Polanczyk A; Demyanets S; Mittlboeck M; Hofmann M; Domenig CM; Neumayer C; Wojta J; Klinger M; Nanobachvili J; Huk I
    Eur J Vasc Endovasc Surg; 2015 May; 49(5):549-55. PubMed ID: 25800096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease.
    Serralheiro P; Novais A; Cairrão E; Maia C; Costa Almeida CM; Verde I
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR.
    Simi L; Andreani M; Davini F; Janni A; Pazzagli M; Serio M; Orlando C
    Lung Cancer; 2004 Aug; 45(2):171-9. PubMed ID: 15246188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.
    Wieczorek E; Reszka E; Jablonowski Z; Jablonska E; Krol MB; Grzegorczyk A; Gromadzinska J; Sosnowski M; Wasowicz W
    BJU Int; 2013 Dec; 112(8):1207-14. PubMed ID: 23819551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.